Hikma Pharmaceutical | HIK - Ebitda


Hikma Pharmaceutical reported $369M in EBITDA for its fiscal semester ending in December of 2024.





Ebitda Change Date
Almirall EUR 114.07M 60.37M Dec/2025
argenx SE USD 539M 6M Sep/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Autolus Therapeutics Ltd USD -56.8M 13.28M Mar/2026
Bayer EUR 2.14B 2.31B Jun/2026
Fresenius EUR 988M 37M Jun/2026
Genmab DKK 401M 186M Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
GRIFOLS EUR 473M 120M Jun/2026
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lakefront Biotherapeutics EUR -63.7M 624.2M Mar/2026
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.6B 69M Jun/2026
Orion EUR 225.5M 33.6M Sep/2026
Recordati EUR 256.6M 26.98M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sanofi EUR 5.79B 2.1B Sep/2026
UCB EUR 1.6B 570M Dec/2025